COMMUNIQUÉS West-GlobeNewswire

Avis de publication des résultats financiers de MDxHealth pour l'exercice 2017
15/02/2018
ANNONCE D'ENTREPRISE INFORMATIONREGLEMENTAIRE INFORMATION PRIVILEGIEE Avis de publication des résultats financiers de MDxHealth pour l'exercice 2017 Une conférence téléphonique pour les analystes et les investisseurs [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
15/02/2018
REGULATED INFORMATION GHENT, Belgium, 15 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Santhera Obtains Worldwide Exclusive License from Polyphor to Develop and Commercialize Clinical Stage Candidate for Cystic Fibrosis and Other Pulmonary Diseases
15/02/2018
Pratteln, Switzerland, February 15, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that it has entered into a license agreement with Polyphor Ltd. for POL6014, a clinical stage selective inhibitor of human [...]
Arbutus Enters Exclusivity Agreement with Roivant Sciences
15/02/2018
VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced [...]
Bradmer Pharmaceuticals Announces Closing of Private Placement of Subscription Receipts and Signing of Arrangement Agreement in Connection With Proposed Business Combination Between Bradmer, Galaxy Digital and First Coin
15/02/2018
Private placement raises gross proceeds of approximately C$305 million to solidify Galaxy Digital’s dedicated blockchain and cryptocurrency merchant banking platform NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR [...]
Antares Pharma Announces FDA Approval of Partner’s Product Utilizing Our QuickShot Auto Injector
15/02/2018
EWING, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced the successful regulatory outcome of the Makena ® subcutaneous auto injector collaboration with AMAG Pharmaceuticals ( [...]
AMAG Pharmaceuticals Announces FDA Approval of Makena® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector to Reduce the Risk of Preterm Birth in Certain At-Risk Women
15/02/2018
WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that the U.S. Food and Drug Administration (FDA) approved the Makena® subcutaneous auto-injector drug-device [...]
TearLab Provides Updates on Its Osmolarity Test and TearLab Discovery™ Platform
14/02/2018
SAN DIEGO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”) today announced its plans to appeal a recent ruling from the Federal Court of Canada related to its [...]
Dentsply Sirona Declares Quarterly Cash Dividend
14/02/2018
YORK, Pa., Feb. 14, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0. [...]
Flexion Therapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference
14/02/2018
BURLINGTON, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President [...]
MyoKardia to Present at the RBC Capital Markets’ 2018 Healthcare Conference
14/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
MacroGenics Announces Date of Fourth Quarter and Full Year 2017 Financial Results Conference Call
14/02/2018
ROCKVILLE, MD, Feb. 14, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Precision Optics Corporation, Inc. Announces Operating Results for the Second Quarter and Six Months of Fiscal Year 2018
14/02/2018
GARDNER, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) today announced operating results on an unaudited basis for its fiscal year 2018 second quarter and six [...]
Xtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private Placement
14/02/2018
Exchange of $70.238M (plus interest) of convertible notes into 10,401,309 shares of common stock at $7.20 per share. $6.809M Private Placement representing 945,819 shares of common stock at $7.20 per share. BELGRADE, [...]
Prothena Reports Fourth Quarter and Full Year 2017 Financial Results, and Provides Financial Guidance and R&D Update
14/02/2018
Net cash used in operating and investing activities was $39.9 million in the fourth quarter and $134.7 million for the full year 2017; quarter-end cash and restricted cash position of $421.7 million supports advancement [...]
AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of Directors
14/02/2018
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus ( [...]
Fluidigm to Participate in Upcoming Health Care Investor Conferences
14/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that the company’s management will participate in two upcoming investor conferences. Chris Linthwaite, [...]
Ultragenyx to Host Conference Call for Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
14/02/2018
NOVATO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results
14/02/2018
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a pharmaceutical company developing therapies for ophthalmic diseases, today reported financial results and operating highlights for [...]

Pages